Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

BEZAFIBRATE CRS (100 MG)

BEZAFIBRATE CRS (100 MG)

41859-67-0

DISCOVER
BIOTIN CRS (20 MG)

BIOTIN CRS (20 MG)

58-85-5

DISCOVER
BIPERIDEN HYDROCHLORIDE CRS (60 MG)

BIPERIDEN HYDROCHLORIDE CRS (60 MG)

1235-82-1

DISCOVER
BIPERIDEN IMPURITY A CRS (20 MG)

BIPERIDEN IMPURITY A CRS (20 MG)

NA

DISCOVER
BISACODYL CRS (30 MG)

BISACODYL CRS (30 MG)

603-50-9

DISCOVER
BLEOMYCIN SULFATE CRS (7 MG)

BLEOMYCIN SULFATE CRS (7 MG)

9041-93-4

DISCOVER
BORDETELLA PERTUSSIS MOUSE ANTISERUM BRP (100 MG)

BORDETELLA PERTUSSIS MOUSE ANTISERUM BRP (100 MG)

NA

DISCOVER
BROMAZEPAM CRS - * PSY (60 MG)

BROMAZEPAM CRS - * PSY (60 MG)

1812-30-2

DISCOVER
BROMHEXINE HYDROCHLORIDE CRS (200 MG)

BROMHEXINE HYDROCHLORIDE CRS (200 MG)

611-75-6

DISCOVER
BROMOCRIPTINE MESILATE CRS (30 MG)

BROMOCRIPTINE MESILATE CRS (30 MG)

22260-51-1

DISCOVER
BROMPERIDOL CRS (100 MG)

BROMPERIDOL CRS (100 MG)

10457-90-6

DISCOVER
BROMPERIDOL DECANOATE CRS (60MG)

BROMPERIDOL DECANOATE CRS (60MG)

75067-66-2

DISCOVER